Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury
Yao Yu, Man Fang, Cailiang Shen · 2026
Read Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury by Yao Yu, Man Fang, Cailiang Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194289.txt.
Description
Yao Yu, Man Fang, and Cailiang Shen test a combined stem cell product against spinal cord injury. Published in 2026, the study primes bone marrow stem cells with platelet rich plasma, then harvests the exosomes the cells release. Priming made the cells grow faster and shed more exosomes, whose cargo shifted: one small RNA, miR-29a-3p, rose the most.
In cell and animal injury models the primed exosomes beat both plain exosomes and plasma alone. They kept neurons alive, curbed cell death and self digestion, and aided nerve regrowth. Tracing the signal showed the RNA acts through PTEN onto a growth pathway, confirmed by rescue tests. The authors propose the primed product as a stronger cell free therapy.
Catalog record
| CREATOR | Yao Yu, Man Fang, Cailiang Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |